[{"address1": "301 Route 17 North", "address2": "Suite 800", "city": "Rutherford", "state": "NJ", "zip": "07070", "country": "United States", "phone": "201 842 7715", "website": "https://glucotrack.com", "industry": "Medical Instruments & Supplies", "industryKey": "medical-instruments-supplies", "industryDisp": "Medical Instruments & Supplies", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack, a non-invasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain through a small sensor clipped onto the earlobe. It is also developing the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.", "fullTimeEmployees": 11, "companyOfficers": [{"maxAge": 1, "name": "Mr. Paul V. Goode Ph.D.", "age": 56, "title": "CEO, President & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 350000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Avner  Gal MBA, MSc.EE", "age": 70, "title": "Co-Founder, Chairman Emeritus, Consultant and Member of Scientific & Clinical Advisory Board", "yearBorn": 1954, "fiscalYear": 2024, "totalPay": 187386, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Malka BA", "age": 59, "title": "Co-Founder", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 191856, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter C. Wulff", "age": 65, "title": "CFO, Treasurer & Secretary", "yearBorn": 1959, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Tapsak Ph.D.", "age": 55, "title": "Chief Scientific Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 165000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Drinda  Benjamin", "age": 48, "title": "Vice President of Marketing", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.64, "open": 7.41, "dayLow": 6.9, "dayHigh": 7.45, "regularMarketPreviousClose": 6.64, "regularMarketOpen": 7.41, "regularMarketDayLow": 6.9, "regularMarketDayHigh": 7.45, "payoutRatio": 0.0, "beta": 0.218, "volume": 105449, "regularMarketVolume": 105449, "averageVolume": 1698440, "averageVolume10days": 165360, "averageDailyVolume10Day": 165360, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 6655634, "fiftyTwoWeekLow": 4.22, "fiftyTwoWeekHigh": 2928.0, "allTimeHigh": 780000.0, "allTimeLow": 4.22, "fiftyDayAverage": 5.9503, "twoHundredDayAverage": 42.833076, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -2632366, "profitMargins": 0.0, "floatShares": 850266, "sharesOutstanding": 899410, "sharesShort": 391903, "sharesShortPriorMonth": 19830, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.4357, "heldPercentInsiders": 0.05548, "heldPercentInstitutions": 0.008090001, "shortRatio": 0.1, "shortPercentOfFloat": 0.4645, "impliedSharesOutstanding": 899410, "bookValue": 7.649, "priceToBook": 0.96744674, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -26770000, "trailingEps": -2441.21, "lastSplitFactor": "1:60", "lastSplitDate": 1750032000, "enterpriseToEbitda": 0.171, "52WeekChange": -0.9971035, "SandP52WeekChange": 0.17904854, "quoteType": "EQUITY", "currentPrice": 7.4, "recommendationKey": "none", "totalCash": 9555000, "totalCashPerShare": 10.624, "ebitda": -15356000, "totalDebt": 267000, "quickRatio": 3.097, "currentRatio": 3.266, "debtToEquity": 3.881, "returnOnAssets": -1.77933, "returnOnEquity": -14.909499, "freeCashflow": -9791875, "operatingCashflow": -14324000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "GCTK", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "GlucoTrack, Inc.", "exchange": "NCM", "messageBoardId": "finmb_99948334", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "longName": "GlucoTrack, Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1759535621, "regularMarketTime": 1759521601, "regularMarketChangePercent": 11.4458, "regularMarketPrice": 7.4, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1366896600000, "postMarketChangePercent": 3.9189184, "postMarketPrice": 7.69, "postMarketChange": 0.28999996, "regularMarketChange": 0.76, "regularMarketDayRange": "6.9 - 7.45", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1698440, "fiftyTwoWeekLowChange": 3.1800003, "fiftyTwoWeekLowChangePercent": 0.7535546, "fiftyTwoWeekRange": "4.22 - 2928.0", "fiftyTwoWeekHighChange": -2920.6, "fiftyTwoWeekHighChangePercent": -0.9974727, "fiftyTwoWeekChangePercent": -99.71035, "epsTrailingTwelveMonths": -2441.21, "fiftyDayAverageChange": 1.4496999, "fiftyDayAverageChangePercent": 0.24363475, "twoHundredDayAverageChange": -35.433075, "twoHundredDayAverageChangePercent": -0.8272363, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "GlucoTrack", "trailingPegRatio": null, "__fetch_time": "2025-10-04"}]